324 related articles for article (PubMed ID: 33589522)
1. WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Want MY; Tsuji T; Singh PK; Thorne JL; Matsuzaki J; Karasik E; Gillard B; Cortes Gomez E; Koya RC; Lugade A; Odunsi K; Battaglia S
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589522
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
Yin Z; Sun Y; Ge S; Sun J
Oncol Rep; 2017 Apr; 37(4):2286-2294. PubMed ID: 28260054
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate Cancer.
Want MY; Karasik E; Gillard B; McGray AJR; Battaglia S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445452
[TBL] [Abstract][Full Text] [Related]
4. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
Toyokawa G; Cho HS; Masuda K; Yamane Y; Yoshimatsu M; Hayami S; Takawa M; Iwai Y; Daigo Y; Tsuchiya E; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
Neoplasia; 2011 Oct; 13(10):887-98. PubMed ID: 22028615
[TBL] [Abstract][Full Text] [Related]
5. The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
Kojima M; Sone K; Oda K; Hamamoto R; Kaneko S; Oki S; Kukita A; Machino H; Honjoh H; Kawata Y; Kashiyama T; Asada K; Tanikawa M; Mori-Uchino M; Tsuruga T; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Osuga Y; Fujii T
BMC Cancer; 2019 May; 19(1):455. PubMed ID: 31092221
[TBL] [Abstract][Full Text] [Related]
6. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
Ezponda T; Popovic R; Shah MY; Martinez-Garcia E; Zheng Y; Min DJ; Will C; Neri A; Kelleher NL; Yu J; Licht JD
Oncogene; 2013 Jun; 32(23):2882-90. PubMed ID: 22797064
[TBL] [Abstract][Full Text] [Related]
7. Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis.
Li Q; Zhu J; Zhang Y; Pan Y; Li Z; Wang M; Gao Y; Feng D; He X; Zhang C
Sci Rep; 2023 Dec; 13(1):21629. PubMed ID: 38062230
[TBL] [Abstract][Full Text] [Related]
8. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
Liu C; Jiang YH; Zhao ZL; Wu HW; Zhang L; Yang Z; Hoffman RM; Zheng JW
Anticancer Res; 2019 Jun; 39(6):2729-2737. PubMed ID: 31177108
[TBL] [Abstract][Full Text] [Related]
10. LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
Battaglia S; Karasik E; Gillard B; Williams J; Winchester T; Moser MT; Smiraglia DJ; Foster BA
Clin Epigenetics; 2017; 9():82. PubMed ID: 28811844
[TBL] [Abstract][Full Text] [Related]
11. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck.
Saloura V; Cho HS; Kiyotani K; Alachkar H; Zuo Z; Nakakido M; Tsunoda T; Seiwert T; Lingen M; Licht J; Nakamura Y; Hamamoto R
Mol Cancer Res; 2015 Feb; 13(2):293-304. PubMed ID: 25280969
[TBL] [Abstract][Full Text] [Related]
12. Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.
Yang P; Guo L; Duan ZJ; Tepper CG; Xue L; Chen X; Kung HJ; Gao AC; Zou JX; Chen HW
Mol Cell Biol; 2012 Aug; 32(15):3121-31. PubMed ID: 22645312
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes.
Wang J; Duan Z; Nugent Z; Zou JX; Borowsky AD; Zhang Y; Tepper CG; Li JJ; Fiehn O; Xu J; Kung HJ; Murphy LC; Chen HW
Cancer Lett; 2016 Aug; 378(2):69-79. PubMed ID: 27164560
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2.
Yamada-Okabe T; Imamura K; Kawaguchi N; Sakai H; Yamashita M; Matsumoto N
Biochem Biophys Res Commun; 2010 Nov; 402(2):335-9. PubMed ID: 20946879
[TBL] [Abstract][Full Text] [Related]
15. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
[TBL] [Abstract][Full Text] [Related]
16. Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity.
Ren J; Li N; Pei S; Lian Y; Li L; Peng Y; Liu Q; Guo J; Wang X; Han Y; Zhang G; Wang H; Li Y; Jiang J; Li Q; Tan M; Peng J; Hu G; Xiao Y; Li X; Lin M; Qin J
J Clin Invest; 2022 Apr; 132(8):. PubMed ID: 35230972
[TBL] [Abstract][Full Text] [Related]
17. WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck.
Saloura V; Vougiouklakis T; Bao R; Kim S; Baek S; Zewde M; Bernard B; Burkitt K; Nigam N; Izumchenko E; Dohmae N; Hamamoto R; Nakamura Y
Neoplasia; 2020 Aug; 22(8):283-293. PubMed ID: 32497898
[TBL] [Abstract][Full Text] [Related]
18. Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway.
Kuo CH; Chen KF; Chou SH; Huang YF; Wu CY; Cheng DE; Chen YW; Yang CJ; Hung JY; Huang MS
Carcinogenesis; 2013 Nov; 34(11):2600-9. PubMed ID: 23955539
[TBL] [Abstract][Full Text] [Related]
19. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome.
Nimura K; Ura K; Shiratori H; Ikawa M; Okabe M; Schwartz RJ; Kaneda Y
Nature; 2009 Jul; 460(7252):287-91. PubMed ID: 19483677
[TBL] [Abstract][Full Text] [Related]
20. Wolf-Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation.
Yu C; Yao X; Zhao L; Wang P; Zhang Q; Zhao C; Yao S; Wei Y
Neoplasia; 2017 Aug; 19(8):606-616. PubMed ID: 28654864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
